Articles from Materna Medical, Inc.

Materna Medical, a women’s health company dedicated to developing innovative solutions for pelvic floor disorders, today announced the successful completion of enrollment in its EASE pivotal trial (NCT03973281). The trial enrolled 420 first-time mothers to evaluate the safety and effectiveness of the investigational Ellora™ Obstetrical System for reducing pelvic muscle injury during vaginal delivery in first-time mothers.

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds.

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, today announced the presentation of baseline data from the ongoing observational clinical trial Prospective On Market Patient-reported Outcomes for Milli™ Vaginal Dilator (the POMPOM study) at the International Society for the Study of Women's Sexual Health (ISSWSH) Annual Clinical Meeting in Atlanta, Georgia, from February 27 to March 2, 2025.

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, announces the publication of encouraging clinical results in the article “Effect of an intrapartum pelvic dilator device on levator ani muscle avulsion during primiparous vaginal delivery: A pilot randomized controlled trial” in the August Issue of the International Urogynecology Journal.

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, is proud to announce the launch of a new clinical study, Prospective On Market Patient-reported Outcomes for Milli™ Vaginal Dilator (POMPOM). This groundbreaking clinical investigation aims to gather valuable data on the effectiveness of the Milli Vaginal Dilator to help relieve the symptoms of vaginismus and related painful intercourse.

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of the first close of a $20 million Series B2 financing round. The round was led by InnovaHealth Partners and other key existing investors included Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, Golden Seeds, Band of Angels, and Houston Angel Network.